Menu
Not yet recruiting NCT06715423

High Flow Nasal Oxygen Therapy an Implementation Study in Pediatric Wards

Observational Moderate Respiratory Distress Severe Respiratory Distress

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
This is an observational study: the protocol does not assign a study treatment.
Who it may be relevant to
Registry conditions: Moderate Respiratory Distress, Severe Respiratory Distress. Basic parameters: 1 months — 5 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Afghanistan
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Overview

The purpose of this study is to prospectively evaluate the process of implementing HFNO in several MSF projects, varying according to geographical and programmatic contexts, population, health structures, human resources, and management. It will generate evidence on the operational feasibility (in terms of human resources, equipment, logistics and costs) of integrating HFNO into PICU standard of care, as well as on the users' and caregivers' perspectives on HFNO and on the children clinical outcomes observed where HFNO is implemented. This relevant information will guide MSF in the decision making of scaling up HFNO therapy in its projects.

Detailed description

Mixed method study: quantitative component for the data of the children and qualitative data for the perception for health staffs and parents

Primary outcome measures

  • Recovery with SPO2 above 92% [Time frame: From enrollment to day 3 to 10]

Eligibility criteria

Inclusion criteria

  • prescription of HFNO by clinician
  • parent consenting to the use of the data

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Observational model
Other

Study locations

Afghanistan · 1 center
  • Herat regional Hospital — Herat

Identifiers

NCT: NCT06715423 · G2429-HFNO_ProcessEvaluation

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗